5-Fluorouracil tattooing for idiopathic guttate hypomelanosis - 14/03/18
Doi : 10.1016/j.jaad.2017.10.033
Carlos Gustavo Wambier, MD, PhD a, ⁎ 
, Sarah Perillo de Farias Wambier, MD, PhD a, Maria Teresa Pereira Soares, MD b, Juliano Breunig, MD, PhD c, Mark Aaron Cappel, MD d, Marina Landau, MD e
, Sarah Perillo de Farias Wambier, MD, PhD a, Maria Teresa Pereira Soares, MD b, Juliano Breunig, MD, PhD c, Mark Aaron Cappel, MD d, Marina Landau, MD e a Department of Medicine, State University of Ponta Grossa, Ponta Grossa, Brazil
b private practice, Sao Sebastiao do Paraiso, Brazil
c Department of Medicine, University of Santa Cruz do Sul, Santa Cruz do Sul, Brazil
d Department of Dermatology, Mayo Clinic, Jacksonville, Florida
e Private Practice, Herzlia Pituach, Israel
∗Reprint requests: Carlos Gustavo Wambier, MD, PhD, Department of Medicine, State University of Ponta Grossa, Bloco M - Campus UEPG Uvaranas Av General Carlos Cavalcanti, 4748, 84030-900, Ponta Grossa, PR, Brazil.Department of MedicineState University of Ponta GrossaBloco M - Campus UEPG Uvaranas Av General Carlos Cavalcanti, 4748Ponta GrossaPR84030-900Brazil
Graphical abstract |
Key words : drug delivery, 5-fluorouracil, idiopathic guttate hypomelanosis, melanocytes, tattoo equipment
Plan
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
© 2017
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 78 - N° 4
P. e81-e82 - avril 2018 Retour au numéro
Article précédent
- Beyond JAAD April 2018: Articles of interest to dermatologists from the nondermatologic literature
- Andrew Bronin, Robert Phelps, Robert Sidbury
- A novel, noninvasive anesthetic method for neurotoxin injection for palmar hyperhidrosis
- Lauren Lam, Susan Poelman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?